Microglial Membranes Wrapped Ultrasmall Medium‐Entropy Ru Single‐Atom Nanozyme: Enhanced Catalysis for Accelerating Inflammation/Redox Microenvironment Regulation in Intracerebral Hemorrhage
Authors:
Top Cited Papers
Open Access
- 4 January 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (18) , e20714
Abstract
Intracerebral hemorrhage (ICH) causes severe secondary brain injury (SBI) via excessive inflammation and reactive oxygen species (ROS), and current treatments lack effective dual‐target efficacy. In this study, we designed a microglial membrane‐wrapped single‐atom nanozyme (PtRhIr/Ru SAN@M) by anchoring a single atom of Ru onto ultrasmall, medium‐entropy PtRhIr alloys. This design integrates two underutilized strategies, single‐atom nanozymes (SANs) and medium‐entropy catalysts, to address critical therapeutic gaps in ICH therapy. PtRhIr/Ru SAN@M exhibited enhanced catalytic activity with superior Hydroxyl radical (•OH) scavenging and superoxide dismutase (SOD)‐like and catalase (CAT)‐like performances compared to Ru‐free PtRhIr@M, enabled by electronically modulated active sites. Fluorescence imaging confirmed its ability to penetrate the blood‐brain barrier (BBB) and accumulate in post‐ICH neuroinflammatory regions. Both in vitro and in vivo experiments demonstrated that PtRhIr/Ru SAN@M repolarized microglia from the M 1 to the M 2 phenotype, disrupting the neuroinflammatory cycle and halting neuronal death. Therapeutic intervention with PtRhIr/Ru SAN@M significantly increased survival rates, restored neurological function, and enhanced spatial memory after ICH. This study pioneers the integration of SANs with medium‐entropy alloys for ICH, offering a dual‐target ROS‐inflammation regulatory strategy and a generalizable platform for ROS‐related degenerative disease therapies.Keywords
This publication has 59 references indexed in Scilit:
- Polyphenol Oxidase‐Like NanozymesAdvanced Materials, 2025
- Atomic‐Level High‐Entropy Nanozymes Enable Remarkable Endogenous Targeted Catalysis and Enhancing Tumor Photothermal TherapyAdvanced Materials, 2025
- Ruthenium Single‐Atom Nanozyme Driven Sonosensitizer with Oxygen Vacancies Enhances Electron–Hole Separation Efficacy and Remodels Tumor Microenvironment for Sonodynamic‐Amplified FerroptosisAdvanced Science, 2025
- Ultrasmall High‐Entropy‐Alloy Nanozyme Catalyzed In Vivo ROS and NO Scavenging for Anti‐Inflammatory TherapyAdvanced Healthcare Materials, 2024
- Biomimetic Nanomotors for Deep Ischemia Penetration and Ferroptosis Inhibition in Neuroprotective Therapy of Ischemic StrokeAdvanced Materials, 2024
- Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant ChemistryAdvanced Functional Materials, 2024
- Minocycline‐Loaded Cerium Oxide Nanoparticles for the Enhanced Treatment of Intracerebral HemorrhageAdvanced Functional Materials, 2024
- Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke TherapyAdvanced Materials, 2024
- Current Advances on the Single‐Atom Nanozyme and Its BioapplicationsAdvanced Materials, 2023
- A Thrombin‐Activated Peptide‐Templated Nanozyme for Remedying Ischemic Stroke via Thrombolytic and Neuroprotective ActionsAdvanced Materials, 2023